PDCD1 and neoplasm: PD-1 signaling is activated by its two ligands PD-L1 and PD-L2 [114,115], which can be expressed in myeloid cells as well on tumor cell surface, thus representing a mechanism by which they can steer the microenvironment toward an immunosuppressive one [113,116].